Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Completed × Lymphoma, Follicular × High-Intensity Interval Training × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Polycystic Ovary Syndrome 8 Motor Activity 7 Prostatic Neoplasms 2 Urinary Bladder Neoplasms 1 Rectal Neoplasms 1 Non-Muscle Invasive Bladder Neoplasms 1 Neoplasms 1 Multiple Endocrine Neoplasia Type 1 1 Lymphoma, Follicular 1 Lupus Erythematosus, Systemic 1 Insulin Resistance 1 Hematologic Neoplasms 1 Head and Neck Neoplasms 1 Fatigue 1 Diabetes Mellitus, Type 1 1 Colorectal Neoplasms 1 Cardiovascular Diseases 1 Cardiotoxicity 1 Carcinoma, Hepatocellular 1 Breast Neoplasms 1 Arthritis, Rheumatoid 1 Anxiety Disorders 1

Interventions

Rituximab 152 Cyclophosphamide 127 Peripheral Blood Stem Cell Transplantation 66 Filgrastim 57 Etoposide 56 fludarabine phosphate 54 Radiotherapy 48 Vincristine 43 Prednisone 42 Mycophenolic Acid 36 Whole-Body Irradiation 35 Melphalan 33 Doxorubicin 33 Cyclosporine 33 Cytarabine 29 Busulfan 29 Tacrolimus 26 Lenalidomide 26 Carmustine 23 Bendamustine Hydrochloride 23 Methylprednisolone 21 Methotrexate 21 Antilymphocyte Serum 21 Bortezomib 20 Dexamethasone 18 sargramostim 17 ibrutinib 17 ibritumomab tiuxetan 17 fludarabine 17 obinutuzumab 16

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04902092 2023-10-23

BEAT

Monash University

Phase NA Completed

Lymphoma, Follicular

Data powered by HemOnc (CC BY 4.0) Colophon ⚡